[CYCC] QoQ Quarter Result on 30-Jun-2013 [#Q2]

Stock
[CYCC] Cyclacel Pharmaceuticals, Inc.
Announcement Date
14-Aug-2013
Financial Year
2013
Quarter
30-Jun-2013 [#Q2]
Profit Trend
QoQ- 146.37%
YoY- 139.95%
Quarter Report
CYCC's Result
CYCC's Financial Summary
View:
Show?
Quarter Result
31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 CAGR
Revenue 396 299 309 264 212 5 38 377.78%
PBT -5,446 -4,026 -5,746 1,248 -3,356 -5,067 -3,572 32.50%
Tax -569 -452 -730 -230 -258 -637 -419 22.65%
NP -4,869 -3,559 -5,004 1,429 -3,082 -4,764 -1,890 88.03%
Tax Rate - - - 18.43% - - - -
Total Cost 5,265 3,858 5,313 -1,165 3,294 4,769 1,928 95.49%
Ratio Analysis
31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 CAGR
NP Margin -1,229.55 -1,190.30 -1,619.42 541.29 -1,453.77 -95,280.00 -4,973.68 -60.64%
Per Share
31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 CAGR
EPS -59.83 -44.87 -67.51 24.00 -75.55 -149.01 -53.81 7.33%
EPS Diluted -59.83 -44.87 -67.51 24.00 -75.55 -149.01 -53.81 7.33%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.